Shortened telomeres in essential thrombocythemia: clinicopathological and treatment correlations

Haematologica. 2018 Jun;103(6):e234-e236. doi: 10.3324/haematol.2017.180851. Epub 2017 Nov 30.

Authors

Samah Alimam^{1

2}, Donal P McLornan^{1

2}, Jie Jiang², Deepti Radia¹, Ghulam J Mufti², Claire N Harrison³

Affiliations

¹ Department of Haematology, Guy's and St. Thomas NHS Foundation Trust, London, UK.
² Department of Haematological Medicine, King's College, London, UK.
³ Department of Haematology, Guy's and St. Thomas NHS Foundation Trust, London, UK Claire.Harrison@gstt.nhs.uk.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers
Blood Cell Count
Combined Modality Therapy
Female
Genetic Predisposition to Disease
Humans
Male
Middle Aged
Mutation
Platelet Count
Telomere Shortening*
Thrombocythemia, Essential / diagnosis
Thrombocythemia, Essential / genetics*
Thrombocythemia, Essential / therapy
Young Adult

Substances

Biomarkers